HAVN Life Logo White

The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-disciplinary collaboration
creating positive experiences and outcomes.


Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.


Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

HAVN Life Announces Retail Partnership with Grocer, Choices Markets

Newly-launched line of natural health products to be available at all locations later this month Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: …

Read More →
Press Releases

HAVN Life Launches New Line of Natural Health Products

Seven new formulations that support brain health and immune function will be available online and at select retail locations starting June 3 Vancouver, BC – …

Read More →
Press Releases

HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug

The Company will seek Orphan Drug Designation to significantly reduce time to market Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: …

Read More →
Scroll to Top